US Patent 11993641 Methods for modulating an immune response
Patent 11993641 was granted and assigned to Cue Biopharma on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+47 properties)
Article (+489 characters)
US Patent 11993641 Methods for modulating an immune response
Article
Patent abstract
The present disclosure provides methods of modulating an immune response in an individual. The present disclosure provides methods of treatment. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) and an immune checkpoint inhibitor to an individual. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) to an individual who is undergoing treatment with immune checkpoint inhibitor.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Rodolfo J. Chaparro0
Ronald D. Seidel, III0
Date of Patent
May 28, 2024
0Patent Application Number
182270570
Date Filed
July 27, 2023
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11993641 Methods for modulating an immune response
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
